A Re-emergence of Subacute Sclerosing Panencephalitis in the United Kingdom
- PMID: 36410008
- DOI: 10.1097/INF.0000000000003744
A Re-emergence of Subacute Sclerosing Panencephalitis in the United Kingdom
Abstract
New pediatric and adult subacute sclerosing panencephalitis cases between 1996 and 2020 were reported based on an established UK registry with no evidence of under-ascertainment using a separate pediatric surveillance system. After 15 years with no pediatric UK-acquired cases, 3 cases arose from 2017 after increased measles. Modeling suggested this was in line with measles notifications, underreporting of laboratory-confirmed measles or increased subacute sclerosing panencephalitis risk.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Campbell H, Andrews N, Brown KE, et al. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol. 2007;36:1334–1348.
-
- European Centre for Disease Prevention and Control. Risk assessment: who is at risk of measles in the EU/EAA? May 28, 2019. Available at: ( europa.eu ). Accessed September 18, 2022.
-
- Miller C, Andrews N, Rush M, et al. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990–2002. Arch Dis Child. 2004;89:1145–1148.
-
- Schonberger K, Ludwig M-S, Wildner M, et al. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS One. 2013;8:e689091–e689098.
-
- Wendorf KA, Winter K, Zipprich J, et al. Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated. Clin Infect Dis. 2017;65:226–232.
MeSH terms
LinkOut - more resources
Full Text Sources
